---
authors:
- Crespo, Cortney
- Erlich, Deborah
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38574221/
file_path: 2024/03/fezolinetant-veozah-for-the-treatment-of-menopause-symptoms.md
issue: '3'
keywords:
- Humans
- Menopause
- Heterocyclic Compounds, 2-Ring
- Hot Flashes
- Thiadiazoles
- Female
last_updated: '2025-07-30'
mesh_terms:
- Female
- Humans
- Menopause
- Heterocyclic Compounds, 2-Ring
- Thiadiazoles
- Hot Flashes
original_format: PubMed
pages: 273-274
patient_population: Adults
peer_reviewed: true
pmid: '38574221'
processed_date: '2025-07-30'
publication_date: '2024-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Fezolinetant (Veozah) for the Treatment of Menopause Symptoms.
topics:
- Family Medicine
volume: '109'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38574221'
  title: Fezolinetant (Veozah) for the Treatment of Menopause Symptoms.
  authors:
  - last_name: Crespo
    fore_name: Cortney
    initials: C
    affiliation: Tufts University School of Medicine, Boston, Massachusetts.
  - last_name: Erlich
    fore_name: Deborah
    initials: D
    affiliation: Tufts University School of Medicine, Boston, Massachusetts.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '109'
    issue: '3'
  publication_info:
    year: '2024'
    month: '03'
    full_date: '2024-03-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Female
    major_topic: false
  - descriptor: Humans
    major_topic: false
  - descriptor: Menopause
    major_topic: false
  - descriptor: Heterocyclic Compounds, 2-Ring
    major_topic: true
  - descriptor: Thiadiazoles
    major_topic: true
  - descriptor: Hot Flashes
    major_topic: false
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '38574221'
  title: Fezolinetant (Veozah) for the Treatment of Menopause Symptoms.
  authors:
  - name: Crespo C
    authtype: Author
    clusterid: ''
  - name: Erlich D
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Mar
- pmid: '37339088'
  title: Fezolinetant (Veozah) for menopausal vasomotor symptoms.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Jun 26
- pmid: '38161058'
  title: A Novel Nonhormonal Treatment for Vasomotor Symptoms of Menopause.
  authors:
  - name: Javernick JA
    authtype: Author
    clusterid: ''
  source: Nurs Womens Health
  pubdate: 2024 Feb
- pmid: '37462862'
  title: 'Fezolinetant: First Approval.'
  authors:
  - name: Lee A
    authtype: Author
    clusterid: ''
  source: Drugs
  pubdate: 2023 Aug
- pmid: '38517209'
  title: 'Finding SKYLIGHT for all: fezolinetant efficacy for vasomotor symptoms in
    subpopulations.'
  authors:
  - name: Reed SD
    authtype: Author
    clusterid: ''
  source: Menopause
  pubdate: 2024 Apr 1
---

# Fezolinetant (Veozah) for the Treatment of Menopause Symptoms.

**Authors:** Crespo, Cortney, Erlich, Deborah

**Published in:** American family physician | Vol. 109, No. 3 | 2024-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38574221/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Female, Humans, Menopause, Heterocyclic Compounds, 2-Ring, Thiadiazoles, Hot Flashes

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38574221/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
